EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Why it is timely to bring a new hormonal male contraceptive to the public – A 35‐year perspective of the authors

Ronald S Swerdloff iD, William J Bremner

Andrology · 2024

DOI: 10.1111/andr.13724 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Andrology, 2024. Verfasst von Ronald S Swerdloff und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Endocrinology, The Lundquist Institute and Harbor-UCLA Medical Center, Torrance, California, USA. Hauptthemen laut MEDLINE: Contraceptive Agents, Male, Testosterone. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This perspective provides an overview of issues needed to bring a testosterone‐progestogen combined transdermal male hormonal contraceptive to the market. Large‐scale phase 2b trials are near completion and a pivotal trial to confirm efficacy and safety has been designed. We believe we are close to accomplishing the steps necessary to bring the first male‐directed effective, safe, and reversible pharmaceutical contraceptive approach to the public. If successful, we believe it will provide a new option for couples to consider in their family planning.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Contraceptive Agents, MaleTestosteroneHumansMaleProgestinsContraceptive Agents, Hormonal

Stichwörter der Autor:innen

availability of male contraceptivesnew male contraceptive methodspharmaceutical industryreproductive rightssharing family planning responsibilities

Substanzen

Contraceptive Agents, MaleTestosteroneProgestinsContraceptive Agents, Hormonal

Autor:innen und Institutionen

  • Department of Medicine, Division of Endocrinology, The Lundquist Institute and Harbor-UCLA Medical Center, Torrance, California, USA.
  • Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA.

ORCID-Profile: Ronald S Swerdloff

Zitieren

APA

Swerdloff, R. S., & Bremner, W. J. (2024). Why it is timely to bring a new hormonal male contraceptive to the public – A 35‐year perspective of the authors. Andrology. https://doi.org/10.1111/andr.13724

Vancouver

Swerdloff RS, Bremner WJ. Why it is timely to bring a new hormonal male contraceptive to the public – A 35‐year perspective of the authors. Andrology. 2024. doi:10.1111/andr.13724

BibTeX
@article{Swerdloff2024,
  author = {Swerdloff, Ronald S and Bremner, William J},
  title = {Why it is timely to bring a new hormonal male contraceptive to the public – A 35‐year perspective of the authors},
  journal = {Andrology},
  year = {2024},
  doi = {10.1111/andr.13724}
}
Kostenlos starten →